{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T15:04:12Z","timestamp":1790867052129,"version":"4.1.0"},"reference-count":51,"publisher":"SAGE Publications","issue":"4","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["High Altitude Medicine &amp; Biology"],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:p>\n                    Berger, Marc Moritz, Peter H. Hackett, and Peter B\u00e4rtsch. No relevant analogy between COVID-19 and acute mountain sickness.\n                    <jats:italic toggle=\"yes\">High Alt Med Biol<\/jats:italic>\n                    . 21:315\u2013318, 2020.\u2014Clinicians and scientists have suggested therapies for coronavirus disease-19 (COVID-19) that are known to be effective for other medical conditions. A recent publication suggests that pathophysiological mechanisms underlying acute mountain sickness (a syndrome of nonspecific neurological symptoms typically experienced by nonacclimatized individuals at altitudes &gt;2500\u2009m) may overlap with the mechanisms causing COVID-19. In this short review, we briefly evaluate this mistaken analogy and demonstrate that this concept is not supported by scientific evidence.\n                  <\/jats:p>","DOI":"10.1089\/ham.2020.0147","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T16:35:21Z","timestamp":1600965321000},"page":"315-318","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":6,"title":["No Relevant Analogy Between COVID-19 and Acute Mountain Sickness"],"prefix":"10.1177","volume":"21","author":[{"given":"Marc Moritz","family":"Berger","sequence":"first","affiliation":[{"name":"Department of Anesthesiology and Intensive Care Medicine, University Hospital Essen, Essen, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H.","family":"Hackett","sequence":"additional","affiliation":[{"name":"Altitude Research Center, Division of Pulmonary Sciences and Critical Care Medicine, Department of Medicine, University of Colorado Anschutz Medical Campus, Aurora, Colorado, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"B\u00e4rtsch","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University of Heidelberg, Heidelberg, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2020,12,21]]},"reference":[{"key":"e_1_3_4_2_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2015432"},{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1089\/1527029041352108"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199110313251805"},{"key":"e_1_3_4_5_1","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMcp1214870","article-title":"Clinical practice: Acute high-altitude illnesses","volume":"368","author":"Bartsch P","year":"2013","unstructured":"Bartsch P, , and Swenson ER. (2013). Clinical practice: Acute high-altitude illnesses. N Engl J Med, 368:2294\u20132302.","journal-title":"N Engl J Med"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.1089\/15270290260512846"},{"key":"e_1_3_4_7_1","doi-asserted-by":"crossref","first-page":"1700982","DOI":"10.1183\/13993003.00982-2017","article-title":"Inhaled budesonide does not prevent acute mountain sickness after rapid ascent to 4559\u2009m","volume":"50","author":"Berger MM","year":"2017","unstructured":"Berger MM, , Macholz F, , Sareban M, , Schmidt P, , Fried S, , Dankl D, , Niebauer J, , Bartsch P, , and Mairbaurl H. (2017). Inhaled budesonide does not prevent acute mountain sickness after rapid ascent to 4559\u2009m. Eur Respir J, 50:1700982.","journal-title":"Eur Respir J"},{"key":"e_1_3_4_8_1","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1152\/japplphysiol.00305.2019","article-title":"Acute mountain sickness: Do different time courses point to different pathophysiologic mechanisms?","volume":"128","author":"Berger MM","year":"2019","unstructured":"Berger MM, , Sareban M, , and Bartsch P. (2019). Acute mountain sickness: Do different time courses point to different pathophysiologic mechanisms?. J Appl Physiol (1985), 128:952\u2013959.","journal-title":"J Appl Physiol (1985)"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2015.0098"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020006000"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(02)07496-2"},{"key":"e_1_3_4_12_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00185808"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2017-001783"},{"key":"e_1_3_4_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.04.015"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200107123450206"},{"key":"e_1_3_4_16_1","first-page":"950","article-title":"Dexamethasone for prevention and treatment of acute mountain sickness","volume":"59","author":"Hackett PH","year":"1988","unstructured":"Hackett PH, , Roach RC, , Wood RA, , Foutch RG, , Meehan RT, , Rennie D, , and Mills WJJr. (1988). Dexamethasone for prevention and treatment of acute mountain sickness. Aviat Space Environ Med, 59:950\u2013954.","journal-title":"Aviat Space Environ Med"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.280.22.1920"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1006\/cyto.1999.0533"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2014.29.3.416"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-118-8-199304150-00003"},{"key":"e_1_3_4_21_1","article-title":"The cytokine storm and COVID-19","author":"Hu B","year":"2020","unstructured":"Hu B, , Huang S, , and Yin L. (2020). The cytokine storm and COVID-19. J Med Virol [Epub ahead of print]; DOI: 10.1002\/jmv.26232.","journal-title":"J Med Virol [Epub ahead of print]"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10557-010-6239-7"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198403153101103"},{"key":"e_1_3_4_24_1","first-page":"208","article-title":"Hemodynamic and sympathoadrenal responses to altitude in humans: Effect of dexamethasone","volume":"59","author":"Johnson TS","year":"1988","unstructured":"Johnson TS, , Rock PB, , Young JB, , Fulco CS, , and Trad LA. (1988). Hemodynamic and sympathoadrenal responses to altitude in humans: Effect of dexamethasone. Aviat Space Environ Med, 59:208\u2013212.","journal-title":"Aviat Space Environ Med"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1152\/japplphysiol.00391.2011"},{"key":"e_1_3_4_26_1","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1152\/jappl.1996.81.5.1917","article-title":"Evidence against an increase in capillary permeability in subjects exposed to high altitude","volume":"81","author":"Kleger GR","year":"1996","unstructured":"Kleger GR, , Bartsch P, , Vock P, , Heilig B, , Roberts LJ, , 2nd, and Ballmer PE. (1996). Evidence against an increase in capillary permeability in subjects exposed to high altitude. J Appl Physiol (1985), 81:1917\u20131923.","journal-title":"J Appl Physiol (1985)"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198912213212504"},{"key":"e_1_3_4_28_1","doi-asserted-by":"crossref","unstructured":"Li X and Ma X. (2020). Acute respiratory failure in COVID-19: Is it \u201ctypical\u201d ARDS? Crit Care 24:198.","DOI":"10.1186\/s13054-020-02911-9"},{"key":"e_1_3_4_29_1","doi-asserted-by":"crossref","unstructured":"Lipman GS Pomeranz D Burns P Phillips C Cheffers M Evans K Jurkiewicz C Juul N and Hackett P. (2017). Budesonide versus acetazolamide for prevention of acute mountain sickness. Am J Med 131:200.e209\u2013200.e216.","DOI":"10.1016\/j.amjmed.2017.05.034"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2020.0055"},{"key":"e_1_3_4_31_1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1513\/AnnalsATS.202004-327CME","article-title":"COVID-19 lung injury and high altitude pulmonary edema: A false equation with dangerous implications","volume":"17","author":"Luks AM","year":"2020","unstructured":"Luks AM, , and Swenson ER. (2020). COVID-19 lung injury and high altitude pulmonary edema: A false equation with dangerous implications. Ann Am Thorac Soc, 17:918\u2013921.","journal-title":"Ann Am Thorac Soc"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2017.0144"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2016.0024"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-145-7-200610030-00007"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.103.16.2078"},{"key":"e_1_3_4_36_1","doi-asserted-by":"crossref","unstructured":"Recovery Collaborative Group; Horby P Lim WS Emberson JR Mafham M Bell JL Linsell L Staplin N Brightling C Ustianowski A Elmahi E Prudon B Green C Felton T Chadwick D Rege K Fegan C Chappell LC Faust SN Jaki T Jeffery K Montgomery A Rowan K Juszczak E Baillie JK Haynes R Landray MJ. (2020). Dexamethasone in hospitalized patients with COVID-19\u2014Preliminary report. N Engl J Med [Epub ahead of print]; DOI: 10.1056\/NEJMoa2021436.","DOI":"10.1056\/NEJMoa2021436"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201108-1396OC"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2017.0164"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1111\/head.13941"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/00005768-200212000-00005"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1152\/jappl.1988.64.6.2605"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1249\/01.mss.0000229102.37359.af"},{"key":"e_1_3_4_43_1","first-page":"7343","article-title":"Acetazolamide, nifedipine and phosphodiesterase inhibitors: Rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (COVID-19)","volume":"12","author":"Solaimanzadeh I.","year":"2020","unstructured":"Solaimanzadeh I. (2020). Acetazolamide, nifedipine and phosphodiesterase inhibitors: Rationale for their utilization as adjunctive countermeasures in the treatment of coronavirus disease 2019 (COVID-19). Cureus, 12:e7343.","journal-title":"Cureus"},{"key":"e_1_3_4_44_1","doi-asserted-by":"crossref","unstructured":"Soliz J Schneider-Gasser EM Arias-Reyes C Aliaga-Raduan F Poma-Machicao L Zubieta-Calleja G Furuya WI Trevizan-Bau P Dhingra RR and Dutschmann M. (2020). Coping with hypoxemia: Could erythropoietin (EPO) be an adjuvant treatment of COVID-19? Respir Physiol Neurobiol 279:103476.","DOI":"10.1016\/j.resp.2020.103476"},{"key":"e_1_3_4_45_1","doi-asserted-by":"crossref","first-page":"2001362","DOI":"10.1183\/13993003.01362-2020","article-title":"To compare the incomparable: COVID-19 pneumonia and high altitude disease","volume":"55","author":"Strapazzon G","year":"2020","unstructured":"Strapazzon G, , Hilty MP, , Bouzat P, , Pratali L, , Brugger H, , and Rauch S. (2020). To compare the incomparable: COVID-19 pneumonia and high altitude disease. Eur Respir J, 55:2001362.","journal-title":"Eur Respir J"},{"key":"e_1_3_4_46_1","first-page":"499","article-title":"Acute mountain sickness is not altered by a high carbohydrate diet nor associated with elevated circulating cytokines","volume":"68","author":"Swenson ER","year":"1997","unstructured":"Swenson ER, , MacDonald A, , Vatheuer M, , Maks C, , Treadwell A, , Allen R, , and Schoene RB. (1997). Acute mountain sickness is not altered by a high carbohydrate diet nor associated with elevated circulating cytokines. Aviat Space Environ Med, 68:499\u2013503.","journal-title":"Aviat Space Environ Med"},{"key":"e_1_3_4_47_1","doi-asserted-by":"crossref","first-page":"2000258","DOI":"10.2807\/1560-7917.ES.2020.25.11.2000258","article-title":"Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19)","volume":"25","author":"Tolksdorf K","year":"2020","unstructured":"Tolksdorf K, , Buda S, , Schuler E, , Wieler LH, , and Haas W. (2020). Influenza-associated pneumonia as reference to assess seriousness of coronavirus disease (COVID-19). Euro Surveill, 25:2000258.","journal-title":"Euro Surveill"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2017.0126"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.7326\/M20-2003"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(09)70014-6"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1089\/ham.2013.1151"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30566-3"}],"container-title":["High Altitude Medicine &amp; Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/ham.2020.0147","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/ham.2020.0147","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/ham.2020.0147","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T07:24:48Z","timestamp":1777447488000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/ham.2020.0147"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":51,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12,1]]}},"alternative-id":["10.1089\/ham.2020.0147"],"URL":"https:\/\/doi.org\/10.1089\/ham.2020.0147","relation":{},"ISSN":["1527-0297","1557-8682"],"issn-type":[{"value":"1527-0297","type":"print"},{"value":"1557-8682","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,1]]}}}